A landmark year for Poolbeg Pharma #POLB – Alan Green talks to CEO Jeremy Skillington July 29, 2022 – Posted in: Blog, Poolbeg Pharma (POLB)

A landmark year for Poolbeg Pharma #POLB – Alan Green talks to CEO Jeremy Skillington, who takes us through what has been a very eventful year since the IPO. At 01:58 we discuss the flagship asset POLB 001, which reached a major milestone last week as it commenced a human challenge trial. At 05:00 Jeremy provides an overview of two collaborations in Artificial Intelligence and how Poolbeg will use these pioneering approaches to identify new treatments for…

Continue reading

Power Metal Resources #POW – Alan Green and Paul Johnson discuss the latest developments December 1, 2021 – Posted in: Blog

Power Metal Resources #POW – Alan Green and Paul Johnson discuss the latest developments during November, including the FDR Australia acquisition and Selta uranium project addition, Alamo gold project developments, Kavango Resources’ stake in Kalahari Key Minerals and Molopo Farms and the upcoming Golden Metal Resources IPO. Paul also gives his view on the share price and the malaise in junior mining stocks.

Continue reading

Poolbeg Pharma #POLB – Exec Chairman Cathal Friel & CEO Jeremy Skillington talk to Alan Green November 9, 2021 – Posted in: Blog, Open Orphan (ORPH), Poolbeg Pharma (POLB)

Poolbeg Pharma #POLB Exec Chairman Cathal Friel and CEO Jeremy Skillington talk to Alan Green about the company’s ‘capital light’ business model. We discuss the POLB 001 asset, spun out of Open Orphan #ORPH, data samples, the PredictViral and vaccine discovery platforms plus further pipeline products. Cathal discusses the company cash position, and Jeremy highlights the upcoming value inflection points for investors and shareholders.

Continue reading